enVVeno Medical (NVNO) Gross Margin (2017 - 2019)

enVVeno Medical's quarterly Gross Margin came in at 100.0% in Q1 2019, little changed quarter-over-quarter from 100.0% in Q4 2018.

enVVeno Medical has reported Gross Margin for 3 years, with the latest figure at 100.0% in Q1 2019.

  • For the quarter ending Q1 2019, Gross Margin changed N/A year-over-year to 100.0%; the trailing twelve-month figure through Mar 2019 stood at 100.0% (changed N/A YoY), and the FY2018 full-year result was 100.0%, up 9942.0% from the prior year.
  • Gross Margin for Q1 2019 stood at 100.0%, roughly flat from 100.0% in the prior quarter.
  • The five-year high for Gross Margin was 100.0% in Q2 2017, with the low at 376.83% in Q3 2017.
  • Average Gross Margin over 3 years is 23.89%, with a median of 100.0% recorded in 2017.
  • Peak annual rise in Gross Margin reached 47683 bps in 2018, while the deepest fall reached 0 bps in 2018.
  • Tracing NVNO's Gross Margin over 3 years: stood at 44.05% in 2017, then surged by 127 bps to 100.0% in 2018, then changed by 0 bps to 100.0% in 2019.
  • The last three Gross Margin figures came in at 100.0% (Q1 2019), 100.0% (Q4 2018), and 100.0% (Q3 2018), per Business Quant data.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Gross Margin (Qtr)
1 Abbott Laboratories 152.82 Bn 146.17 Bn 6.27 Bn 56.20%
2 Stryker 115.07 Bn 112.19 Bn 3.81 Bn 63.29%
3 Medtronic 95.25 Bn 87.08 Bn 5.76 Bn 63.83%
4 Boston Scientific 71.38 Bn 70.17 Bn 3.61 Bn 69.46%
5 Edwards Lifesciences 51.08 Bn 47.41 Bn 1.29 Bn 78.01%
6 Koninklijke Philips 29.38 Bn 26.07 Bn 2.07 Bn 45.22%
7 Dexcom 28.84 Bn 27.72 Bn 750.30 Mn 62.95%
8 GE HealthCare Technologies 28.56 Bn 26.49 Bn 1.98 Bn 38.53%
9 Steris 20.71 Bn 20.30 Bn 697.10 Mn 43.89%
10 enVVeno Medical 6.99 Mn 6.99 Mn - -

Historic Data

Download Data 🔒
DateValue
Mar 31, 2019 100.00%
Dec 31, 2018 100.00%
Sep 30, 2018 100.00%
Jun 30, 2018 100.00%
Dec 31, 2017 44.05%
Sep 30, 2017 -376.83%
Jun 30, 2017 100.00%